Marine Organisms with Anti-Diabetes Properties

Overview

Journal Mar Drugs

Publisher MDPI

Specialties Biology
Pharmacology

Date 2016 Dec 6

PMID 27916864

Citations 37

Authors

Chiara Lauritano

Adrianna Ianora

Affiliations

Soon will be listed here.

Abstract

Diabetes is a chronic degenerative metabolic disease with high morbidity and mortality rates caused by its complications. In recent years, there has been a growing interest in looking for new bioactive compounds to treat this disease, including metabolites of marine origin. Several aquatic organisms have been screened to evaluate their possible anti-diabetes activities, such as bacteria, microalgae, macroalgae, seagrasses, sponges, corals, sea anemones, fish, salmon skin, a shark fusion protein as well as fish and shellfish wastes. Both in vitro and in vivo screenings have been used to test anti-hyperglycemic and anti-diabetic activities of marine organisms. This review summarizes recent discoveries in anti-diabetes properties of several marine organisms as well as marine wastes, existing patents and possible future research directions in this field.

Citing Articles

Antioxidative, Glucose Management, and Muscle Protein Synthesis Properties of Fish Protein Hydrolysates and Peptides.

Shekoohi N, Carson B, FitzGerald R J Agric Food Chem. 2024; 72(39):21301-21317.

PMID: 39297866 PMC: 11450812. DOI: 10.1021/acs.jafc.4c02920.

Revolutionizing Diabetes Care: The Role of Marine Bioactive Compounds and Microorganisms.

Reddy K, Rakesh K, Prathyusha S, Gupta J, Nagasree K, Lokeshvar R Cell Biochem Biophys. 2024; 83(1):193-213.

PMID: 39254792 DOI: 10.1007/s12013-024-01508-1.

Antioxidant and Skin-Whitening Efficacy of a Novel Decapeptide (DP, KGYSSYICDK) Derived from Fish By-Products.

Lee S, Hwang J, Kang H Mar Drugs. 2024; 22(8).

PMID: 39195491 PMC: 11355700. DOI: 10.3390/md22080374.

Isolation and Identification of Lichen Photobionts Collected from Different Environments in North of Portugal and Evaluation of Bioactivities of Their Extracts.

Loureiro L, Morais J, Silva R, Martins J, Geada P, Vasconcelos V Foods. 2024; 13(11).

PMID: 38890987 PMC: 11172358. DOI: 10.3390/foods13111759.

Seaweeds as Nutraceutical Elements and Drugs for Diabetes Mellitus: Future Perspectives.

Cotas J, Lomartire S, Pereira L, Valado A, Marques J, Goncalves A Mar Drugs. 2024; 22(4).

PMID: 38667785 PMC: 11051413. DOI: 10.3390/md22040168.

References

Romano G, Costantini M, Sansone C, Lauritano C, Ruocco N, Ianora A . Marine microorganisms as a promising and sustainable source of bioactive molecules. Mar Environ Res. 2016; 128:58-69. DOI: 10.1016/j.marenvres.2016.05.002. View

Sonksen P, Sonksen J . Insulin: understanding its action in health and disease. Br J Anaesth. 2000; 85(1):69-79. DOI: 10.1093/bja/85.1.69. View

Gokce G, Haznedaroglu M . Evaluation of antidiabetic, antioxidant and vasoprotective effects of Posidonia oceanica extract. J Ethnopharmacol. 2007; 115(1):122-30. DOI: 10.1016/j.jep.2007.09.016. View

Nakao Y, Uehara T, Matsunaga S, Fusetani N, Soest R, Matunaga S . Callyspongynic acid, a polyacetylenic acid which inhibits alpha-glucosidase, from the marine sponge Callyspongia truncata. J Nat Prod. 2002; 65(6):922-4. DOI: 10.1021/np0106642. View

Reimann M, Bonifacio E, Solimena M, Schwarz P, Ludwig B, Hanefeld M . An update on preventive and regenerative therapies in diabetes mellitus. Pharmacol Ther. 2009; 121(3):317-31. DOI: 10.1016/j.pharmthera.2008.11.009. View

Malve H . Exploring the ocean for new drug developments: Marine pharmacology. J Pharm Bioallied Sci. 2016; 8(2):83-91. PMC: 4832911. DOI: 10.4103/0975-7406.171700. View

Zhu C, Li G, Peng H, Zhang F, Chen Y, Li Y . Effect of marine collagen peptides on markers of metabolic nuclear receptors in type 2 diabetic patients with/without hypertension. Biomed Environ Sci. 2010; 23(2):113-20. DOI: 10.1016/S0895-3988(10)60040-2. View

Zhang Z, Zhao M, Wang J, Ding Y, Dai X, Li Y . Oral administration of skin gelatin isolated from Chum salmon (Oncorhynchus keta) enhances wound healing in diabetic rats. Mar Drugs. 2011; 9(5):696-711. PMC: 3111176. DOI: 10.3390/md9050696. View

Sun Z, Liu J, Zeng X, Huangfu J, Jiang Y, Wang M . Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. Food Funct. 2011; 2(5):251-8. DOI: 10.1039/c1fo10021a. View

10.

Shi D, Guo S, Jiang B, Guo C, Wang T, Zhang L . HPN, a synthetic analogue of bromophenol from red alga Rhodomela confervoides: synthesis and anti-diabetic effects in C57BL/KsJ-db/db mice. Mar Drugs. 2013; 11(2):350-62. PMC: 3640384. DOI: 10.3390/md11020350. View

11.

Okada Y, Ishimaru A, Suzuki R, Okuyama T . A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. J Nat Prod. 2004; 67(1):103-5. DOI: 10.1021/np030323j. View

12.

Imada C . Enzyme inhibitors and other bioactive compounds from marine actinomycetes. Antonie Van Leeuwenhoek. 2005; 87(1):59-63. DOI: 10.1007/s10482-004-6544-x. View

13.

Yamazaki H, Sumilat D, Kanno S, Ukai K, Rotinsulu H, Wewengkang D . A polybromodiphenyl ether from an Indonesian marine sponge Lamellodysidea herbacea and its chemical derivatives inhibit protein tyrosine phosphatase 1B, an important target for diabetes treatment. J Nat Med. 2013; 67(4):730-5. PMC: 3765847. DOI: 10.1007/s11418-012-0735-y. View

14.

Sagar S, Kaur M, Minneman K . Antiviral lead compounds from marine sponges. Mar Drugs. 2010; 8(10):2619-38. PMC: 2992996. DOI: 10.3390/md8102619. View

15.

Kang C, Jin Y, Lee H, Cha M, Sohn E, Moon J . Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways. Food Chem Toxicol. 2009; 48(2):509-16. DOI: 10.1016/j.fct.2009.11.004. View

16.

Pandey S, Sree A, Dash S, Sethi D, Chowdhury L . Diversity of marine bacteria producing beta-glucosidase inhibitors. Microb Cell Fact. 2013; 12:35. PMC: 3639877. DOI: 10.1186/1475-2859-12-35. View

17.

Iwai K . Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A(y) mice. Plant Foods Hum Nutr. 2008; 63(4):163-9. DOI: 10.1007/s11130-008-0098-4. View

18.

Kimura Y, Watanabe K, Okuda H . Effects of soluble sodium alginate on cholesterol excretion and glucose tolerance in rats. J Ethnopharmacol. 1996; 54(1):47-54. DOI: 10.1016/0378-8741(96)01449-3. View

19.

Klotz U . Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review. Int J Clin Pharmacol Ther. 2006; 44(10):478-83. DOI: 10.5414/cpp44478. View

20.

Kim K, Nam K, Kurihara H, Kim S . Potent alpha-glucosidase inhibitors purified from the red alga Grateloupia elliptica. Phytochemistry. 2008; 69(16):2820-5. DOI: 10.1016/j.phytochem.2008.09.007. View